OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator. This document is also available as Markdown.

← The Association Of Coloproctology Of Great Britain And Ireland

2024-12-31-accounts

Charity registration number 1118063

Company registration number 05962281 (England and Wales)

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND

(REFERRED TO AS ACPGBI)

ANNUAL REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) LEGAL AND ADMINISTRATIVE INFORMATION

Trustees

Mr J Bell Mrs M Bentley Ms J Burch Mr T Cook Dr R Davies Mrs A Demick Professor J Hill Mr D McArthur Miss K Nugent Ms L Peach Mr B Singh Dr J Wheeler Mr H Young

(Appointed 1 January 2024) (Appointed 3 July 2024) (Appointed 1 July 2024) (Appointed 1 January 2024)

Secretary Ms A Sutton Charity number 1118063 Company number 05962281 Registered office The Royal College of Surgeons of England 35-43 Lincoln's Inn Fields London WC2A 3PE Auditor Sumer Audit Piper House 4 Dukes Court Bognor Road Chichester West Sussex PO19 8FX Bankers NatWest Bank Queen Square Wolverhampton WV1 1TL Solicitors Steele Raymond LLP Richmond Point 43 Richmond Hill Bournemouth BH2 6LR Investment advisors Ruffer LLP 80 Victoria Street London SW1E 5JL

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) CONTENTS

Page
Trustees' report 1 - 31
Statement of trustees' responsibilities 32
Independent auditor's report 33 - 36
Statement of financial activities 37
Balance sheet 38
Statement of cash flows 39
Notes to the financial statements 40 - 56

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

The Trustees present their report together with the accounts of the Charity, Association of Coloproctology of Great Britain and Ireland (ACPGBI) for the year ending 31st December 2024.

PUBLIC BENEFIT STATEMENT

The Association of Coloproctology's (ACPGBI) activities include promoting education and research in all matters appertaining to the science, art and treatment of patients with coloproctological disease.

The objectives are to provide specialised knowledge and advanced training, education, research and scholarship in science and technology in cooperation with other bodies to its members to benefit their patients.

In addition, the ACPGBI aims to be a complete resource of knowledge and help to patients with colorectal disease, empowering and ensuring the best treatments are available to all who seek them.

strategic aims and directing its Executive's activities to further these objectives. The Council has had due regard to the Charity Commission's guidance on reporting public benefit.

Strategic aims

provides further information on our progress and achievements against these and other objectives.

1 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

STRUCTURE, GOVERNANCE AND MANAGEMENT

The ACPGBI, established in 1990, was registered with the Charity Commissioners. The charity was an unincorporated Association (registration number 1013924) until 30th June 2007. All the assets of the former charity were transferred to the Association of Coloproctology of Great Britain and Ireland, a company limited by guarantee (company number 05962281) and registered as a charity with the Charity Commission (charity number 1118063).

The ACPGBI business, organisational structure and working practices are governed by its constitution. This document is updated yearly, and any changes are approved at the AGM. ACPGBI is led by an Executive Committee and guided by a representative Council. Administration and marketing are carried out by its Secretariat. The Executive formulates policy and considers all matters concerning the Association. All decisions are notified to Council regularly for approval. Posts for Council, chapter representatives and major positions (President, Secretary, Treasurer etc.) are advertised on the website and ballots are held where appropriate.

Along with the ACPGBI o�ice bearers (President, Honorary Secretary and Honorary Treasurer), the Executive Committee includes chairs of the Education and Training, External A�airs, Multidisciplinary Clinical and Research and Audit committees.

The executive appointments are made as either 'Assistant' (e.g., secretary and treasurer) or in waiting / elect (e.g., President). This gives appointees su�icient time (2 years) to become thoroughly acquainted with the roles they are due to take up at the Annual Meeting.

The Board of Trustees comprises the Executive members (President, Honorary Secretary and Honorary Treasurer) and non-executive members who include medical (at least five medical trustees and ideally will include one nurse) and lay members. The medical trustees are members with previous experience in holding o�ice in the Association, none of whom currently sit on committees of the Association. The lay members include a minimum of two patient representatives, a lawyer, a trustee from a financial background and a nonmedical academic. Additional or replacement Trustees will be appointed by the Board of Trustees as they see fit, as there are no formal policies for inducting new Trustees.

ACPGBI has undergone a formal risk assessment process to help identify areas of concern and formulate suitable action plans. ACPGBI’s short, medium and long-term priorities and goals are discussed in the annual strategy meetings, and appropriate action plans are finalised.

The following Trustees served the charity from 1st January 2024 to 31st December 2024.

EXECUTIVE TRUSTEES

President:

Mr Justin Davies (appointed 03 July 2024) Professor Jared Torkington (resigned 03 July 2024) Honorary Secretary: Ms Laura Hancock (appointed 03 July 2024) Mr G Branagan (resigned 03 July 2024)

2 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

Honorary Treasurer:

Mr David McArthur

Non-Executive Trustees

Mr J Bell

Mrs M Bentley

Mr T Cook (Chair)

Mrs A Demick

Prof J Hill

Miss K Nugent Mrs J Sanders (resigned 21 October 2024) Mr B Singh Mr H Young

OBJECTIVES AND ACTIVITIES

Principal policies to achieve the objectives

The ACPGBI aims to achieve high standards and advance the science of coloproctology by promoting and publishing the results of research and audit. The charity also provides and disseminates information to help professionals and the public on matters concerning coloproctology. Furthermore, ACPGBI seeks to promote high ethical standards and continues to endorse high standards in training and best clinical practice through its AGM and links with all geographical regions in the UK & Ireland based on regional chapter representation.

Strategy to achieve the objectives

around 1,650 persons, including consultant surgeons, surgeons in training, physicians, pathologists, radiologists, clinical scientists, medical students and clinical nurse specialists with interest in coloproctology.

ACPGBI is one of several specialist institutions within the broad spectrum of general surgery. It has assumed an increasingly important and influential role in the organisation of colorectal services within the United Kingdom and Ireland. ACPGBI is a direct stakeholder in the National Institute for Health and Care Excellence (NICE), contributes to health technology appraisals and is a key advisor to the Royal College of Surgeons in matters relating to coloproctology.

The strength of ACPGBI continues to be its representation throughout the UK & Ireland mediated via the regional chapter structure. Each chapter has meetings to disseminate scientific, best practices and political strategies agreed upon at Council meetings. Equally, in a democratic manner, concerns and clarifications raised at a regional level concerning central policy can be brought back to both the Council and Executive.

The administrative o�ice is responsible for the day-to-day running of the charity and e�ective communication between elected o�icers, chapter representatives and the general membership.

3 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

Since 2014 the Association has controlled the collection of subscriptions from members through its website.

Executive meetings are held four times, and Council meetings are held three times per year in addition to an Annual General Meeting. The Trustees meet thrice a year, under the leadership of the chairperson, and oversee the activities and performance of the Association. The Annual Meeting is the flagship event of the year. It is organised by the President, and in 2024 was held in Newport and attended by nearly 1000 delegates.

Administration

The chief administrator for the Association is Mrs Adele Sutton. The day-to-day management of the Association is delegated to her. Payments to creditors need dual authorisation by Mrs Sutton and the Treasurer. Ms Nicole Taub also works in the o�ice to oversee membership and marketing, which has helped with raising the organisation's profile via social media.

The administration of the Annual Meeting is outsourced to a conference management company.

The administrative centre of ACPGBI is located at the Royal College of Surgeons of England, 35-43 Lincoln's Inn Fields, London WC2A 3PE. Since July 2017, ACPGBI has leased an o�ice directly from the Royal College of Surgeons (RCS) located in the refurbished RCS Building. In line with Association's strategy, in May 2018, ACPGBI set up an independent payroll for our employees, and ACPGBI has its employer reference at HMRC. The website was redesigned under a new company and released in July 2021. This website (www.acpgbi.org.uk) has sections aimed for the public, patients and professionals.

ACHIEVEMENTS AND PERFORMANCE DURING THE YEAR ENDED 31ST DECEMBER 2024 GENERAL

In 2024, the ACPGBI continues to deliver successfully on its activities and strategic objectives. The Association is pleased to have maintained a high level of performance during this demanding post-covid recovery period.

The website underwent further development to make it more user-friendly for both professionals and patients / carers added several updates and new content including position statements and educational activities across the regions. The website has proved its worth as the front end of ACPGBI’s activities.

Face to face events continued following the pandemic, with a wide range of topics covered at local Chapter meetings, educational events arranged by the Dukes’ Club and other ACP-endorsed meetings. The association however made a strategic decision to maintain virtual events like the Advanced Coloproctology Course (ACC) after overwhelming feedback received requesting this format to be continued.

The executive committee and Council met in person to plan and deliver what amounted to an excellent portfolio of activities, events and meetings to the benefit of members and associates. The trustee meetings continued as virtual meetings. There was one face to face trustee meeting in Newport, Wales in July.

The Advanced Coloproctology Course (ACC) was held in March 2024 on a virtual online platform and broadcast presentations of outstanding quality to a large worldwide audience of more than 1000 registrants. This was repeated for this third consecutive year.

The Annual Meeting in July 2024 was held in Newport in a face-to-face venue attended by over 900 delegates. The meeting incorporated cutting-edge developments in management of colorectal diseases, with a strong

4 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

emphasis on patient involvement in most sessions. Unlike the previous year, the meeting made a modest loss.

The committee tasked with supporting medical students with an interest in coloproctology grew its membership and ran events aimed specifically at students. Medical students were supported if they wanted to attend the annual meeting with free registration.

Following a stringent selection process held in 2023, ACPGBI invested a further small amount of money held in the reserve accounts into the already existing Ruffer investment portfolio in August 2024, to guard against inflation.

Executive agreed the development and implementation of a formal, rolling 5-year strategy document, aimed at focussing the workstream of each of the committees, sub-committees and the organisation as a whole. This was developed at Strategy in November 2024.

The salient achievements and aspirations of the ACPGBI events and committees in 2024 are outlined below.

ACPGBI 2024 ANNUAL MEETING

The Annual Meeting was held on 1st – 3rd July 2024 in Newport in a face-to-face venue attended by 920 delegates, providing stimulating educational and networking opportunities.

sponsorship and registration income, other factors not originally budgeted for meant that there was a loss of £49,315.54. A large factor in this loss were additional management fees paid to Integrity Events to help with the conference organisation, a mitigation put in place to cover anticipated Secretariat absence due to sick leave.

The meeting received impressive feedback, both for the educational content and the opportunity to network. The investment in educational pursuit is in line with ACPGBI’s objectives and engagement with the members and professional stakeholders.

and professional stakeholders.
Total registered delegates 920
Paying delegates 610
Complementary delegates 310

EDUCATION & TRAINING COMMITTEE

Overview

The Education and Training Committee meets regularly with their predominant aim being to improve education and training within coloproctology. The Chair represents the views of the committee on the Executive and Council.

The Education and Training Committee oversee many educational activities as outlined below:

5 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

Advanced Coloproctology Course (ACC) 2024

The ACC was held over 2 days in March 2024 and again used Sayso Medical to deliver the event via a virtual platform following feedback from previous courses. Registration fees were kept low, with free registration for medical students and those from low- and middle-income countries (LMICs). The costs of delivering the course were covered by a combination of registration fees and generous industry support. We had over 1000 worldwide registrations and the feedback from delegates was once again excellent, reinforcing that this format is valued by ACPGBI members and non-members alike. Further metrics can be provided. There is a fine balance to cover costs of delivering the course, but the ACPGBI executive have been very supportive in seeing any costs incurred as an investment by ACPGBI in coloproctology education both in Great Britain and Ireland and worldwide.

the ACPGBI to make it as accessible as possible with a review following the Advanced Coloproctology Course 2024.

Fundamentals of Coloproctology Course

We developed and rolled out the Fundamentals of Coloproctology Course in 2023, aimed at more junior resident doctors and allied health professionals, and consisting of a one-day virtual event (“The Theory”) delivered free via the Medall platform in order to allow open access to medical professionals followed by regionally delivered practical workshops (“The Practical”) supported by industry educational partners. The feedback from each component of the course was excellent. Developing this further we have incorporated parts of the Fundamentals of Coloproctology – “The Theory” course into national online core surgical teaching.

Fellowships

ACPGBI continues to support fellowships in association with the Royal College of Surgeons of England.

The ACPGBI received significant industry funding from Intuitive (Intuitive Surgical) in 2023 to fund robotic fellowships via the ACPGBI. Via a competitive selection process 2 units were chosen as the training centres and 4 post CCT robotic fellows were selected following a competitive application and interview processes. The units selected were Colchester and Glasgow with fellowships running October 2024-April 2025 and April-Oct 2025.

Colorectal Focus

This is an educational session within the ACPGBI Annual Meeting which provides an update on core topics for members. The session was well attended at the 2024 meeting. The rolling programme will continue for the 2025 meeting.

ACPGBI and Duke’s Club Trainer of the Year

The Trainer of the Year Award recognises excellence in training and is awarded on a yearly basis after a careful selection process involving the Education and Training committee who consider nominations.

The winner of the ACPGBI and Dukes’ Club Trainer of the Year 2024 was Sarah Du�.

6 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

ACPGBI Trainee Coloproctologist of the Year

This award is designed to identify and highlight colorectal trainees nationally who have been outstanding throughout their training and have shown excellence in the areas of research and academia, leadership and education and training. This initiative provides a platform to recognise and encourage talent amongst colorectal trainees.

The ACPGBI 2024 Trainee Coloproctologist of the Year was awarded to Kat Parmar. The ACPGBI funded the winner to enrol in the Royal College of Surgeons of Edinburgh’s Future Leaders’ Programme.

Medical Student Membership

The medical student committee had a successful year. The ACPGBI funded a number of free places at the annual meeting, including travel bursaries. The Committee held an essay writing competition with a prize supported by the ACPGBI. They also awarded an elective bursary supported by ACPGBI. They held an event for students in Chester with the opportunity for surgical skills training and career guidance.

Optimising Rectal Cancer Outcomes (OReCO) Programme

The ACPGBI continued to support a collaboration with the Pelican Cancer Foundation to facilitate the delivery of the OReCO Programme – a national colorectal MDT workshop for colorectal Multi-disciplinary Teams in GB and Ireland. The programme commenced in early 2024 and will run until the end of 2026.

International work

process and funded by ACPGBI to travel to the UK to attend 2 di�erent centres and also to attend the 2024 annual meeting with the opportunity to give a presentation in the main auditorium.

Other work

The Education and Training Committee continues to support educational activity including collaborations with other organisations. There is an ACPGBI symposium within the ASGBI annual meeting. The committee reviews applications and award CPD points for educational events.

The various subcommittees have organised webinars and ACPGBI has collaborated with the Royal College of Surgeons of Edinburgh to deliver a series of webinars, commencing in 2024 and continuing into 2025. We continue to work with industry partners to help support education and training for our members.

MULTIDISCIPLINARY CLINICAL COMMITTEE (MCC)

Role of Committee

The role of the MCC has historically been to provide leadership for clinical aspects of coloproctology for the ACPGBI.

The MCC responds to requests from external organisations for information and collaboration. The MCC Chair provides guidance and support for the Chairs of the 12 Subcommittees (See below).

7 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

Whereas previously the MCC Chair had a very broad overview and responsibility for all di�erent aspects of clinical coloproctology, the remit of the Chair evolved during 2024 to be a more supportive, leadership role for each of the subcommittee Chairs. The Chair sits on the ACPGBI Executive. Subcommittees:

The Subcommittees have undertaken an enormous amount of activity over the last year, promoting Clinical Guidance and Education for the ACPGBI Membership.

1) Colonoscopy:

Role of Committee:

Goals set out for 2025

Activity during 2024

Close links with British Society of Gastroenterology (BSG) and Joint Advisory Group on GI Endoscopy (JAG) working on workforce data - Career Intentions of the UK Endoscopy Workforce: Results from the 2023 UK-Wide Pan-Workforce Survey. Saiu et al. submitted Frontline Gastroenterology Jan 2025. This expedited National endoscopy strategy with workforce concern, resulting in aim to increase BCSP endoscopists by arranging 30 advanced specialty training modules in colonscopy, funded by National Health Service England for 1 year, across the country in areas of greatest need. This is supported by Dukes’ Club training survey submitted to Frontline Gastroenterology "A survey of the current experience of endoscopy training for colorectal surgical trainees in the United Kingdom" Siggins et al January 2025 suggesting lack of training opportunities.

8 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

This has been promoted through JAG training lead as evidence of inequality of training between surgeons and gastroenterologists and highlighted to British Society of Gastroenterology and training academies, with a view to trying to improve equity of access.

ACPGBI voice is being heard and recent recognition in multiple combined guidelines – British Society of Gastroenterology / ACPGBI FIT guidelines in suspected Colorectal Cancer; British Society of Gastroenterology / ACPGBI surveillance guideline; British Society of Gastroenterology / ACPGBI management hereditary Colorectal Cancer; new FIT / Iron Deficiency Anaemia guidance; management polyps in the elderly; KPIs in colonoscopy update; biopsies in colonoscopy.

We sit as part of NICE health tech programme on DA78 AI software to help detect colorectal polyps.

Dukes’ Club Educational Webinars – Polypectomy September 2024, Highlands’ training December 2024; EMR / Endoscopic Submucosal Dissection complex polyps planned for February 2025. Now o�ered to consultants (last viewed ~160 participants) and British Society of Gastroenterology trainees.

Support with Joint Advisory Group on GI Endoscopy (JAG) / Royal College of Physicians issue about memorandum of understanding and the need for JAG to be independent to be able to easily and unbiasedly represent surgical and other stakeholder views. As such, we may be required to financially support their case against Royal College of Physicians (RCP), however no movement in last 4 months.

Through Endovillage, promoting wider understanding of the evolution of endoscopy and the surgical opportunities with it, particularly in organ preservation and achieving R0 resections endoscopically.

Plans for the future

2)

Role of committee:

Goals set out for the year:

  1. Education

9 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

Activity during the year

Plans for the future:

Continue to run an annual IBD educational meeting – next one planned in collaboration with MidOx, likely end of 2025 - early 2026

Pouch Accreditation will continue to roll-out, with a regular annual review of accredited centres being next Ongoing collaboration with pouch units via pouch accreditation network

10 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

3) Emergency General Surgery (EGS)

Role of Committee:

To provide colorectal Surgeons, trainees and professions allied to medicine resources that will assist in their treatment of Emergency Patients under their care.

Goals set out for the year

Most of the members of the ACPGBI are likely to undertake Emergency on call commitments as part of their clinical role. However, Emergency General Surgery is often an overlooked part of surgical education and research with most in the colorectal sphere more interested in elective management of patients. This sub- committee aims to provide EGS representation to the ACPGBI committee, provide educational resources for the association that are relevant to emergency presentations, and undertake Emergency General Surgery relevant colorectal research in this field.

Activity during the year

These were well attended and received. Feedback was excellent for each session. The format of casebased discussion with a conversational aspect to the panel was successful.

Plans for the future

11 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

4) Advanced Colorectal Malignancy:

The purpose of the Advanced Colorectal Malignancy Sub-Committee is to advise on the optimal management for patients with advanced pelvic colorectal cancer, to develop and support both research and education in advanced colorectal cancer, and to advise NHS England on service provision.

5) Peritoneal Disease:

The purpose of the Peritoneal Malignancy Sub-Committee is to advise on the optimal management for patients with peritoneal metastases from colorectal and appendiceal malignancy, to develop and support both research and education in peritoneal malignancy and to advise NHS England on service provision. The committee will represent and support ACPGBI members.

6) Abdominal Wall:

Role of Committee:

To increase awareness and understanding around abdominal wall defects germane to colorectal surgeons. This includes management of the open abdomen, hernia prevention, incisional and parastomal hernia diagnosis and treatment. The committee aims to improve care for patients a�ected by these conditions through education, engagement at ACPGBI events and through collaboration with other professional and patient groups.

Goals set out for the year:

Activity during the year

Plans for the future

12 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

7) Proctology:

Role of Committee:

To improve the standard of, and maintain the quality of, proctological surgery across Great Britain and Ireland.

Goals set out for the year

Activity during the year

Plans for the future

8) Robotic Surgery:

Role of Committee

Goals set out for the year:

Training

Research

13 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

Governance

Activity during the year

Training

Research

Plans for the future

14 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

9) Intestinal Failure (IF)

Role of Committee

This involves education of surgeons in how best to prevent this complication; education of surgeons in its management, including non-surgical management such as parenteral nutrition, and liaison with relevant sub-committees. This year we have liaised with the abdominal wall committee and the Dukes’ club.

Goals set out for the year

The foremost goal for the year was to develop a document that would be an up-to-date guide for practising surgeons in the management of intestinal failure. This document was planned to be a multiauthor document, with invited contributions from relevant experienced clinicians across the UK.

Other goals included:

Activity during the year

15 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

Plans for the future

10) Cancer

Role of the Committee

The cancer subcommittee holds a comprehensive mandate to serve as an expert resource, addressing all facets necessary to optimise cancer care for our patient population. It aims to enhance training, education, and research opportunities in colorectal cancer, while also contributing to the strategic planning and delivery of prevention and treatment initiatives in partnership with the ACPGBI and external agencies.

Goals for the Year

Activity During the Year

Cancer Subcommittee Structure and Function

16 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

Organised and devised a session at the ACPGBI July meeting on rectal cancer, addressing key topics such as:

Quality Improvement Initiative

Cancer Subcommittee members have attended and contributed to the development of a quality improvement project focused on the optimal use and timely closure of ileostomy after anterior resection for cancer. This project is due to launch in November 2025.

Plans for the Future

11) Guidelines Committee

Role of Committee

17 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

Goals set out for the year

The committee came into being in spring 2024 so no goals were set last year. These are our priorities:

Activity during the year

Plans for the future

12) Research & audit committee

The Research & Audit Committee has an established long-term strategy to:

ACPGBI Joint Research / EYCN Event

This initiative was developed to target new consultants or those in their senior training years, many of whom are not in formal academic posts. The one-day programme included talks on study design, how to publish, how to broaden your impact and career paths in research. The feedback from attendees

18 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

was positive. It was funded by securing industry support as well as support from ACPGBI. It was a joint venture with EYCN designed to build not only clinical but research networks.

Research MDT

We have continued this initiative in 2025 with one successful meeting planned in May 2025 and a further one planned MDT in the autumn. The committee and invited guests provide an expert panel that includes clinician, scientist, trialist / statistician, and a patient representation. Study ideas are submitted and chosen for presentation to the expert panel to provide ideas, contacts, feedback, and connections. The feedback from researchers has been very positive.

Bowel Research App (Joint venture ACPGBI and BRUK)

The committee worked on the app during 2024 and it will be o�icially launched at ACPGBI Harrogate 2025. This joint venture is an app designed to highlight colorectal research studies open to recruitment. Both patients and clinicians can access the app and search for open research projects recruiting by their disease type or local area. It is an exciting initiative designed both to increase recruitment but also to allow clinicians and most importantly patients direct access to research relevant to them.

AGM Celtic Manor 2024

The Research Plenary featured results of breaking trials, updates on existing trials, updates from the Research MDT. Existing trials needing a further recruitment drive were also highlighted. Exciting results from INTACT (ICG fluorescence to prevent anastomotic leak), ACCURE (appendicectomy to induce remission in ulcerative colitis) and NEOPRISM (use of immunotherapy in colorectal cancer) among others were presented. This session also highlighted the importance of Patient and Public Involvement in colorectal research.

AGM Harrogate 2025

The Research Plenary for the 2025 AGM will feature highly anticipated trial results from the MEErKAT (Crohn’s disease anastomosis technique), OCeAN (Preoperative exclusive enteral nutrition in Crohn’s disease and an update on the colorectal cancer vaccine trials as well as updates on breaking trials.

ACPGBI Representation

Bowel Research UK (BRUK)

As a trustee of BRUK, the Chair has worked to strengthen and maintain the relationship between the charity and the Association. The BRUK CEO agreed to attend an ACPGBI executive meeting twice per

19 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

year to update them and BRUK are committed to distributing at least half of their grant funding to projects with an ACPGBI member as a Principal Investigator (PI). A Memorandum of Understanding has been signed to protect this relationship in the future. This relationship has been consolidated through the Bowel Research App. ACPGBI and BRUK jointly appoint the Surgical Specialty Leads (SSLs) to the Royal College of Surgeons. This has been augmented by the appointment of five Associate SSLs who have been central to the Research and Audit committee and have been focussed on promoting colorectal research.

13) External a�airs committee

Role of Committee

The External A�airs Committee of the ACPGBI is responsible for enhancing the organization's public profile and promoting the field of coloproctology among key stakeholders, including surgeons, healthcare professions, other key stakeholders including other charities and the public.

The committee ensures that all ACPGBI communication channels, such as social media and a regular newsletter, are e�ective and professional. Additionally, the committee oversees the website subcommittee, which manages the association's online presence. They also work towards enhanced branding of the ACPGBI.

Goals set out for the year

The main goal of the External A�airs committee is to continue the professionalisation of the branding of the ACPGBI, both to its members and external public groups and individuals, such as patients.

To enhance the branding of the ACPGBI, a multifaceted approach is recommended.

Activity during the year.

20 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

Plans for the future

14) Early years consultant network (EYCN)

Role of committee

The early years consultant network serves ACPGBI members in their transition to consultant life and through the first 5 years of practice. Its key goals are inclusivity, peer support and mentorship. It aims to promote a safe and collaborative environment for consultant and senior trainees to develop the skills necessary to flourish in their career.

Goals set out for the year

The following goals were set for the 12 months –

Activity during the year.

21 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

Plans for the future

In the next 12 months, the following should be addressed –

15) Equality, diversity and inclusion (EDI) committee

Role of committee

Statement).

Through the EDI steering group, we aim to increase engagement with the wider colorectal surgical community / allied healthcare professionals and support their professional growth, simultaneously leading to growth of organisation as well. Our key objective is to support and improve equal representation and career / training progression of healthcare professionals in colorectal surgery.

16)

The Pelvic Floor Society (TPFS) was formed in 2012 and is an a�iliate of ACPGBI.

With now over 500 members the membership grows year-on-year. Approximately two-thirds of members are consultants, mainly colorectal, but also from gastroenterology, gynaecology, urology, pain specialty and radiology. Nurses and Allied health professional members (physiotherapists, and clinical scientists) form the second largest group within the society. All these members have voting rights within our society, creating an inclusive membership. Non-voting members include trainees, overseas specialists and honorary members.

The 15th annual conference was held 13-15 November 2024 in Southampton and featured a preconference study day and a wide range of topical sessions delivered by National and International expects in the field of pelvic floor. The conference received excellent feedback.

TPFS continues to have adequate funds to support further educational events and course. Badged courses include Current Concepts in Faecal Incontinence Course, Cadaveric Rectal Prolapse Course, Endoanal Ultrasound course. It supports three regional sub-chapters in the Northern Pelvic Floor Group, Southern Pelvic Floor Group and Scottish Pelvic Floor Group in educational events.

22 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

Patient education is very much at the forefront of TPFS activity with the development of patient information sheets to support patient decision making and aid informed consent.

In 2024 the TPFS supported a James Lind Alliance Priority Setting Partnership in identifying research priorities for faecal incontinence in adults. This will hopefully generate future funding of investigatory

TPFS provides advice and support externally to NHSe, MRHA and GIRFT for mesh-related issues and has representation in the development of National governance registries for Pelvic Mesh use and Neuromodulation therapies. It runs an accreditation process for pelvic floor units defining standards required to provide optimal clinical care and forms links with other National societies involved in the management of gastroenterology and pelvic floor conditions.

17) Association of coloproctology nurses (ACPN)

The ACPN continues to be a dynamic and essential part of ACPGBI, advocating for specialist nursing, supporting day-to-day clinical practice, and promoting research and education across the profession.

At the 2024 ACPGBI Annual Meeting in Newport, ACPN delivered a strong presence with focused sessions and hands-on learning opportunities.

Monday 1 July featured an in-depth session on Research into Acute Kidney Injury (AKI) and Ileostomy, highlighting critical patient safety issues and sharing best practice.

This was followed by an interactive workshop on Exploring the Research Pillar of Practice, led by Dr Gabrielle Thorpe, Associate Professor at the University of East Anglia, inspiring nurses to engage with research in meaningful and practical ways.

ACPN also maintains a strong voice within the ACPGBI’s clinical subcommittees, ensuring nursing perspectives shape policy, practice, and innovation across colorectal care.

18) Dukes' club

Role of Committee

The Dukes’ Club is the o�icial training arm of the Association of Coloproctology of Great Britain and Ireland. The society is run by elected colorectal surgery trainees to represent the views of trainees across the UK and Ireland on education and training.

Goals set out for the year

23 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

Activity during the year

Throughout the year we worked hard to deliver high-quality educational webinars. This year we have also organised webinars which focus on supporting colorectal trainees who are either a�ected by challenging personal circumstances or have found it di�icult to access training opportunities.

We ran webinars on

Collaboration with ACPGBI for ACC

Dukes participated in ACC and were invited as faculty. The Dukes’ President opened the VIVA session and facilitated with Q+A backstage

Dukes’ Club ran the following courses

Proctology Roadshow. A face-to-face educational day covering the management of anorectal disorders, led by Mr Phil Tozer and supported by the ACPGBI Proctology subcommittee. The following regions have been covered: Scotland, London, East of England, Yorkshire, Midlands, Mersey. Future courses are booked for Cheltenham and Bristol

Fundamentals of Coloproctology- Practical. Our regional representatives have been integral to running the practical part of the Fundamentals of Coloproctology course. We have so far organised this course in the following regions: She�ield, London and Mersey

24 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

Plans for future

19) The Journal - Colorectal Disease

Journal, of the association and remains a jewel in its crown.

The current editor of the journal has a strategic plan for the journal with collaboration with the Association. The publishing agreement between ACPGBI and Wiley for the journal was renewed in December 2022.

25 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

There was a requirement for an Interim Editor in Chief during 2024 to cover illness, which was covered by one of the Junior Editors.

The total journal income for 2024 was £554,704, an increase from £521,505 in 2023.

Institutional subscription revenue declined from £145,482 in 2023 to £132,716 in 2024, continuing the long-term trend driven by the market forces toward open access.

Member revenue increased slightly in 2024, due to the fee for 2023 from the Spanish Association of Coloproctology (AECP) being invoiced in 2024. The AECP agreed to pay 50% of the 2023 fee (£10,000) and this appears in the 2024 account. However, they have decided not to continue their subscription, so this revenue line will decrease in 2025.

Open access revenue increased from £192,137 in 2023 to £264,630 in 2024. More of the journal’s output is now covered by Transformational Agreements, with 96.5% of the OA revenue coming from TAs in 2024. Although the number of OA-eligible articles published in the journal decreased slightly (197 in 2023 moving to 191 in 2024), the number of OA articles increased from 90 to 109. In order to continue this growth in OA revenue, and continue to o�set the decrease in subscription revenue, recommendations were put in plans in place to increase the number of good quality articles published in the journal.

Income from journal rights decreased from £78,608 in 2023 to £61,615 in 2024, while pay-per-view increased slightly. These revenue lines are expected to vary year on year as they are constituted by specific one-time agreements and transactions, but we do anticipate a long-term decline as increasing numbers of articles are available in an open access model.

a royalty arrangement of 30% of all revenues, except the ACPGBI member fees.

The journal is o�icially recognised by Index Medicus and is listed on Medline. The journal's 2-year Impact Factor stands at 2.9 for 2024, down from 3.4 for 2023.

20) ACPGBI Patient Liaison Group (PLG)

Role of Group

The Patient Liaison Group represents the perspective of the lived experience of patients who have been treated for bowel and pelvic diseases, including cancer, inflammatory bowel disease. fistulae and functional bowel disorders. Together with the ACPGBI, the PLG is committed to improving the experience and outcomes of all patients with colorectal disease by pursuing constructive dialogue between clinicians and patients.

The PLG is entirely voluntary and unpaid, meeting bi-monthly via Zoom. Members have considerable lived experience both as patients with colorectal disease and also in patient support groups:

Goals set out for the year

26 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

Activity during the year

ACPGBI 2024

PLG members

Six new members joined the PLG bringing a wider range of experience, diversity and skills to the group. Bob Arnott sadly passed away and is greatly missed from the PLG.

The following are a list of activities in 2024 by members either directly or non-directly related to PLG. Members have often been drawn to the PLG through these activities or may be invited to participate via the PLG so there are not clear boundaries:

27 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

FINANCIAL REVIEW

Financial results 1st January to 31st December 2024

The income to ACPGBI was primarily from direct membership subscriptions and from the Annual General Meeting. Additionally, ACPGBI received a small amount of interest on deposited reserves. Additional income was derived from the Pelvic Floor Society and the Dukes' Club. ACPGBI also received revenue from a profit share arrangement with Wiley, the publisher of the journal Colorectal Disease. The Trustees are confident that all tax liabilities have been recognised and administered.

Expenditure relates to the running costs of the Association, the expenses of running the Annual Meeting and the cost of providing Colorectal Disease to Ordinary Surgical Members and wages and salaries.

Total income from all sources for the period ending 31st December 2024 was £1,319,097. The total expenditure in the period ending 31st December 2024 was £1,399,648. Our investments made a net loss of £25,903. The net expenditure in the period ending 31st December 2024 was £106,454. The total funds on 31st December 2024 in all accounts held by the Association were £1,798,052.

accounting started in January 2023, and continued into 2024 in this manner. Prior to this, records were maintained on MS Excel sheets.

28 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

next financial year was discussed and debated. Plans were made for distribution of funds to support the educational and research priorities of the Association.

Risk analysis

Meeting's financial success depends on the number of delegate registrations, exhibition income and sponsorship, which may vary from year to year.

Currently, the estimated funds required for hosting an Annual Meeting are in the region of £550,000. For this reason, the ACPGBI retains funds of over £550,000 to cover the costs of an Annual Meeting, which may fail due to factors outside the Association's control. Although ACPGBI takes out routine insurance in this respect, including anti-terrorism cover, this would not protect against the general financial reserves and running costs of ACPGBI. In the post-pandemic environment, no insurance policy will cover the loss of capital or revenue from a cancellation or disruption due to a pandemic. The incorporation of ACPGBI has removed the personal financial risk born by the Trustees.

The adoption of virtual meeting platforms enabled the Association to run educational events in the pandemic environment, albeit at a considerable additional expense. In 2024, as in 2022 and 2023, the association decided to keep the advanced coloproctology course (ACC) as a virtual event and the annual meeting as a face-to-face event. The registrations in all events were appreciable and substantial and were worth all the extra e�ort to organise these events.

We have noticed a reduced appetite for sponsoring online virtual events by the industry. The changes in the post-pandemic landscape that a�ect meetings and events will be closely monitored, and appropriate measures will be adopted to mitigate the loss of revenue from such matters.

events moving into 2023 and 2024.

Whilst building up the capital reserve, the investment policy of ACPGBI remains to maintain the current accounts at zero at the end of each working day with automatic transfer of any reserves through the business reserve account for the two main accounts, namely the general account and the Annual Meeting account. The policy prior to 2023 has been to keep the Association's resources in risk-free accounts, rather than invest in other ways, which might bring a higher rate of return, but would carry a risk which could result in a loss of capital and jeopardise both the charity's funds and the Trustees. However, due to inflationary pressures, a decision was made to explore investment options to mitigate losses, and during 2023 the association made its first investment (outlined below).

risk to its Trustees.

Investment Policy

It was evident that over the years, the Association has accumulated surplus cash balances in the two accounts totalling about £800-1000K. The current nominal interest rate earned by the two accounts is 0.01%, which is well below prevailing inflation rates. The rising inflation in the latter half of 2022 exaggerated this depreciation and loss of value in such accounts.

29 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

The net loss over successive years perpetrated a substantial loss of value for the accumulated capital. This net loss was deemed a substandard and unacceptable value to the members' subscriptions and did not stand in good stead for the Association's long-term worth. Depreciation of the reserve cash reduces the capacity of the Association to weather the losses in challenging times such as those imposed by unexpected global occurrences such as the Covid-19 pandemic.

The Honorary Treasurer proposed a framework to mitigate the depreciation of the Association's surplus cash reserves. Initial enquiries led to a series of deliberations which revealed how similar professional associations manage their excess funds. The case for safe investment of surplus funds was discussed in the ACPGBI executive meeting on 20/09/2021. With the concurrence of the Executive and the Trustees, an e�ort to explore safe investment was undertaken by a team of Trustees. A series of virtual meetings with potential stakeholders were conducted.

of which four were shortlisted based on stringent criteria for more detailed discussions. A dedicated virtual presentation meeting with them was attended by key trustees and executives on 5th July 2022. Further deliberations based on company profile, charitable and overall assets under management, environmental and social governance, risk management, access to funds at short notice and assurance on capital preservation were some of the categories analysed for each of the providers. The final choice of Ru�er was ratified in December 2022. The ACPGBI’s investment policy statement (IPS) was drafted in December 2022 and debated elaborately with the stakeholder and the ACPGBI panel before it was finalised in early 2023.

made into an investment fund with Ru�er in August 2023. There is an intention to continue to add to this fund annually, where funds held by the ACPGBI permit, in order that reserves for the Association do no lose value relative to inflation, whilst recognising the charitable aims of the Association and its role in supporting research, education, training, and its other strategic roles. On this basis, £25,000 further monies were deposited in the Ru�er account in July 2024.

Future Financial Strategy

The plans, priorities and actions for the next 12 months are outlined below under principal strategic themes.

Operations:

Revenue stream:

Investments:

30 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

Continue to transfer funds into the investment portfolio based around the investment strategy to protect cash reserve from inflationary loss

Funding fellowships:

Regional activity and initiatives:

Continue limited (max £1,000 per year) funding to facilitate Chapters to run meetings during the year

Annual Meeting:

Industry partnership:

Meet key players to discuss and plan collaboration details

Colorectal disease:

Sta�:

TRUSTEES' RESPONSIBILITIES

The Board of Trustees were set up to add oversight to the governance of ACPGBI, separate from the Executive.

The Trustees (who are also directors of The Association of Coloproctology of Great Britain and Ireland for the purposes of company law) are responsible for preparing the Trustees' Annual Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

an accurate and fair view of the charitable company's state of a�airs and the incoming resources and application of resources, including the income and expenditure of the charitable company for that period. In preparing these financial statements, the Trustees are required to:

31 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024

The Trustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps to prevent and detect fraud and other irregularities.

In so far as the Trustees are aware:

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act relating to small companies.

Report of the trustees, incorporating a strategic report, approved by order of the board of trustees, as the company directors, and signed on the board's behalf.

Approved by the Trustees and signed on their behalf by

Sushil Maslekar

Honorary Treasurer, Association of Coloproctology of Great Britain & Ireland

Dated 29th September 2025

32 | P a g e

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) INDEPENDENT AUDITOR'S REPORT

TO THE TRUSTEES OF THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND

Opinion

We have audited the financial statements of The Association of Coloproctology of Great Britain and Ireland (the ‘charity’) for the year ended 31 December 2024 which comprise the statement of financial activities, the balance sheet, the statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion, the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the charity in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charity’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The trustees are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) INDEPENDENT AUDITOR'S REPORT (CONTINUED)

TO THE TRUSTEES OF THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the charity and its environment obtained in the course of the audit, we have not identified material misstatements in the directors' report included within the trustees' report.

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of trustees

As explained more fully in the statement of trustees' responsibilities, the trustees, who are also the directors of the charity for the purpose of company law, are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the trustees are responsible for assessing the charity’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Identification and assessment of irregularities including fraud

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) INDEPENDENT AUDITOR'S REPORT (CONTINUED)

TO THE TRUSTEES OF THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND

In identifying and assessing risks of material misstatement in respect of irregularities, including fraud and noncompliance with laws and regulations, our procedures included the following:

· Obtaining an understanding of the legal and regulatory framework that the charity operates in, focusing on those laws and regulations that had a direct effect on the financial statements and operations;

· Obtaining an understanding of the charity's policies and procedures on fraud risks, including knowledge of any actual, suspected or alleged fraud;

· Discussing among the engagement team how and where fraud might occur in the financial statements and any potential indicators of fraud through our knowledge and understanding of the company and our sector-specific experience.

As a result of these procedures, we considered the opportunities and incentives that may exist within the association for fraud. We are also required to perform specific procedures to respond to the risk of management override. As a result of performing the above, we identified the following areas as those most likely to have an impact on the financial statements: health & safety and employment law, as well as compliance with the UK Companies and Charities Acts.

In addition to the above, our procedures to respond to risks identified included the following:

· Making enquiries of management about any known or suspected instances of non-compliance with laws and regulations and fraud;

· Reviewing minutes of meetings of the board and senior management.

· Reading correspondence with regulators

· Challenging assumptions and judgements made by management in their significant accounting estimates; and

· Auditing the risk of management override of controls, including through testing journal entries and other adjustments for appropriateness.

Due to the inherent limitations of an audit, there is an unavoidable risk that some material misstatements in the financial statements may not be detected, even though the audit is properly planned and performed in accordance with the ISAs (UK). For instance, the further removed non-compliance is from the events and transactions reflected in the financial statements, the less likely the auditor is to become aware of it or to recognise the non-compliance.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https:// www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND

(REFERRED TO AS ACPGBI) INDEPENDENT AUDITOR'S REPORT (CONTINUED)

TO THE TRUSTEES OF THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND

Use of our report

This report is made solely to the charitable company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Jordan Abbott BSc ACA (Senior Statutory Auditor) for and on behalf of Sumer Audit ......................... Chartered Accountants Statutory Auditor Chichester

Sumer Audit is the trading name of Sumer Auditco Limited

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT

FOR THE YEAR ENDED 31 DECEMBER 2024

Unrestricted
Restricted
funds
funds
2024
2024
Notes
£
£
Income from:
Donations and legacies
3
2,000
-
Charitable activities
Education
4
224,572
3,000
Annual General
Meeting
4
646,555
-
Publication Income
4
163,389
-
Other trading activities
5
264,265
-
Investments
6
15,316
-
Total income
1,316,097
3,000
Charitable activities
Education
7
647,829
1,646
Annual General
Meeting
7
724,243
-
Publication Income
7
50,863
-
Total charitable
expenditure
1,422,935
1,646
Total expenditure
1,422,935
1,646
Net gains/(losses) on
investments
12
(25,903)
-
Net income/(expenditure) and
movement in funds
(132,741)
1,354
Reconciliation of funds:
Fund balances at 1 January
2024
As originally reported
1,895,974
8,532
Prior year adjustment
-
-
As restated
1,895,974
8,532
Fund balances at 31
December 2024
1,763,233
9,886		 Total
Unrestricted
Restricted
funds
funds
2024
2023
2023
£
£
£
2,000
-
-
227,572
186,435
-
646,555
717,221
-
163,389
176,590
-
264,265
276,250
-
15,316
2,138
-
1,319,097
1,358,634
-
649,475
454,212
-
724,243
518,101
-
50,863
55,237
-
1,424,581
1,027,550
-
1,424,581
1,027,550
-
(25,903)
4,574
-
(131,387)
335,658
-
1,904,506
1,544,861
8,532
-
15,455
-
1,904,506
1,560,316
8,532
1,773,119
1,895,974
8,532		 Total
2023
£
-
-
186,435
717,221
176,590
276,250
2,138
1,358,634
454,212
518,101
55,237
1,027,550
1,027,550
4,574
335,658
1,553,393
15,455
1,568,848
1,904,506

The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) BALANCE SHEET

AS AT 31 DECEMBER 2024

2024 2023
Notes £ £ £ £
Fixed assets
Intangible assets 14 26,820 53,159
Tangible assets 15 867 1,289
Investments 16 521,125 506,712
548,812 561,160
Current assets
Stocks 17 15,891 17,113
Debtors 18 348,404 381,332
Cash at bank and in hand 899,500 1,014,552
1,263,795 1,412,997
Creditors: amounts falling due within 19
one year 39,488 69,651
Net current assets 1,224,307 1,343,346
Total assets less current liabilities 1,773,119 1,904,506
The funds of the charity
Restricted income funds 21 9,886 8,532
Unrestricted funds 1,763,233 1,895,974
1,773,119 1,904,506

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the trustees on ......29th September 2025.......

..............................

Sushil Maslekar, ACPGBI Treasurer

Trustee

Company registration number 05962281 (England and Wales)

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) STATEMENT OF CASH FLOWS

FOR THE YEAR ENDED 31 DECEMBER 2024

Notes
Cash flows from operating activities
Cash (absorbed by)/generated from
operations
24
Investing activities
Purchase of intangible assets
Purchase of investments
Investment income received
Net cash used in investing activities
Net cash used in financing activities
Net decrease in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year		 2024
£
£
(85,821)
(4,231)
(40,316)
15,316
(29,231)
-
(115,052)
1,014,552
899,500		 2023
£
£
375,299
(21,920)
(502,138)
2,138
(521,920)
-
(146,621)
1,161,173
1,014,552

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024

1 Accounting policies

Charity information

The Association of Coloproctology of Great Britain and Ireland is a private company limited by guarantee incorporated in England and Wales. The registered office is The Royal College of Surgeons of England, 35-43 Lincoln's Inn Fields, London, WC2A 3PE.

1.1 Accounting convention

The financial statements have been prepared in accordance with the charity's Memorandum and Articles of Association, the Companies Act 2006, FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019). The charity is a Public Benefit Entity as defined by FRS 102.

The financial statements are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2 Going concern

At the time of approving the financial statements, the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3 Charitable funds

Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable objectives.

Restricted funds are subject to specific conditions by donors or grantors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements.

1.4 Income

Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.

Cash donations are recognised on receipt. Other donations are recognised once the charity has been notified of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.

Legacies are recognised on receipt or otherwise if the charity has been notified of an impending distribution, the amount is known, and receipt is expected. If the amount is not known, the legacy is treated as a contingent asset.

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

1 Accounting policies

(Continued)

1.5 Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement, and the amount of the obligation can be measured reliably.

Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges are allocated on the portion of the asset’s use.

1.6 Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computer software and website 33% straight line

1.7 Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings 15% reducing balance Computers 25% reducing balance Chain of Office 20% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the statement of financial activities.

1.8 Fixed asset investments

Fixed asset investments are initially measured at transaction price excluding transaction costs, and are subsequently measured at fair value at each reporting date. Changes in fair value are recognised in net income/(expenditure) for the year. Transaction costs are expensed as incurred.

1.9 Impairment of fixed assets

At each reporting end date, the charity reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

1.10 Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

1 Accounting policies

(Continued)

1.11 Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.12 Financial instruments

The charity has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the charity's balance sheet when the charity becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities

Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of operations from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities

Financial liabilities are derecognised when the charity’s contractual obligations expire or are discharged or cancelled.

1.13 Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the charity is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

1 Accounting policies

(Continued)

1.14 Retirement benefits

The company is a Participating Employer in SAUL. The actuarial valuation applies to SAUL as a whole and does not identify surpluses or deficits applicable to individual employers. As a whole, the market value of SAUL’s assets at 31 March 2023 was £3,096 million representing 105% of the liabilities.

It is not possible to identify an individual Employer’s share of the underlying assets and liabilities of SAUL. The company accounts for its participation in SAUL as if it were a defined contribution scheme and pension costs are based on the amounts actually paid (i.e. cash amounts) in accordance with paragraphs 28.11 of FRS 102.

As there was a Technical Provisions surplus at 31 March 2023, no deficit contributions were required following the 2023 valuation and there is no defined benefit liability (i.e. the present value of any deficit contributions due to SAUL) to be recognised by the company.

2 Critical accounting estimates and judgements

In the application of the charity’s accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3 Income from donations and legacies

Unrestricted Unrestricted
funds funds
2024 2023
£ £
Grants receivable for core activities 2,000 -

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

4 Income from charitable activities

Unrestricted
Restricted
funds
funds
2024
2024
£
£
Education
Pelvic Floor Society
57,155
-
Advanced Coloproctology
course (previously
motorway course)
74,314
-
Dukes' Club
73,319
-
Performance related
grants
-
3,000
Other meetings
19,784
-
Annual General Meeting
Annual General and other
meetings
646,555
-
Publication Income
Publication income
163,389
-
1,034,516
3,000
Income from other trading activities
Subscriptions
Interest receivable
Other trading activities		 Total
Unrestricted
Restricted
Total
funds
funds
2024
2023
2023
2023
£
£
£
£
57,155
70,309
-
70,309
74,314
36,184
-
36,184
73,319
52,142
-
52,142
3,000
-
-
-
19,784
27,800
-
27,800
646,555
717,221
-
717,221
163,389
176,590
-
176,590
1,037,516
1,080,246
-
1,080,246
Unrestricted
Unrestricted
funds
funds
2024
2023
£
£
250,037
262,508
14,228
13,742
264,265
276,250		 Total
2023
£
70,309
36,184
52,142
-
27,800
717,221
176,590
1,080,246
276,250

5 Income from other trading activities

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2024

6 Income from investments

Unrestricted Unrestricted
funds funds
2024 2023
£ £
Income from listed investments 15,286 1,784
Interest receivable 30 354
15,316 2,138

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2024

7 Expenditure on charitable activities

Education
2024
£
Direct costs
Pelvic Floor Society
70,847
Dukes Club
78,582
Chapter meetings
25,561
Travel fellowship
11,291
Other meetings
4,151
AGM and other meetings
-
Subscription to journal
-
Advanced Coloproctology course (previously motorway
course)
39,972
Software and app development
19,200
249,604
Grant funding of activities (see note 8)
89,607
Share of support and governance costs (see note 9)
Support
256,194
Governance
54,070
649,475
Analysis by fund
Unrestricted funds
647,829
Restricted funds
1,646
649,475		 Annual
General
Meeting
Publication
Income
2024
2024
£
£
-
-
-
-
-
-
-
-
-
-
724,243
-
-
50,863
-
-
-
-
724,243
50,863
-
-
-
-
-
-
724,243
50,863
724,243
50,863
-
-
724,243
50,863		 Total
Education
2024
2023
£
£
70,847
47,381
78,582
51,571
25,561
18,293
11,291
10,446
4,151
7,080
724,243
-
50,863
-
39,972
91,303
19,200
-
1,024,710
226,074
89,607
20,377
256,194
190,450
54,070
17,311
1,424,581
454,212
1,422,935
454,212
1,646
-
1,424,581
454,212		 Annual
General
Meeting
Publication
Income
2023
2023
£
£
-
-
-
-
-
-
-
-
-
-
518,101
-
-
55,237
-
-
-
-
518,101
55,237
-
-
-
-
-
-
518,101
55,237
518,101
55,237
-
-
518,101
55,237		 Total
2023
£
47,381
51,571
18,293
10,446
7,080
518,101
55,237
91,303
-
799,412
20,377
190,450
17,311
1,027,550
1,027,550
-
1,027,550

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2024

7 Expenditure on charitable activities

(Continued)

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

8 Grants payable

Education Education
2024 2023
£ £
Grants to institutions:
RCS funding - Surgical Speciality Leads 20,000 1,727
RCS Education funding - Future Leaders programme 7,670 -
NHS Glasgow - Robotic Fellowship 40,000 -
Bowel Research UK - Colorectal research 18,000 18,650
Pelican Cancer Foundation - OReCO Scotland ACPGBI Chapter meeting 1,100 -
86,770 20,377
Grants to individuals 2,837 -
89,607 20,377
9 Support costs allocated to activities
2024 2023
£ £
Staff costs 105,806 104,147
Depreciation 30,992 18,008
Administrative services and rent 54,914 14,256
Printing, postage and stationery 1,358 3,428
Telephone and conference calls - 2,166
Computer maintenance, software and equipment 3,297 8,480
Bank and credit card charges 5,639 820
Subscriptions 688 5,992
Insurance 7,406 8,084
Website and database expenses 8,691 3,987
Payroll, VAT services and legal and professional fees 34,517 19,014
Bad debts and other costs 2,886 2,068
Governance costs 54,070 17,311
310,264 207,761
Analysed between:
Education 310,264 207,761

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

9
Support costs allocated to activities
Governance costs comprise:
Audit fees
Auditors' fees for non-audit work
Accountancy and legal fees
Meetings and travel		 (Continued)
2024
2023
£
£
6,695
6,500
2,250
-
1,379
6,500
43,746
4,311
54,070
17,311		 (Continued)
2024
2023
£
£
6,695
6,500
2,250
-
1,379
6,500
43,746
4,311
54,070
17,311
17,311

10 Trustees

None of the trustees (or any persons connected with them) received any remuneration during the year, but 3 of them were reimbursed a total of £1,885 travelling expenses (2023 - 4 were reimbursed £2,419).

11 Employees

The average monthly number of employees during the year was:

Administration
Employment costs
Wages and salaries
Social security costs
Other pension costs		 2024
Number
2
2024
£
84,627
4,068
17,111
105,806		 2023
Number
2
2023
£
82,760
3,949
17,438
104,147

There were no employees whose annual remuneration was more than £60,000.

Remuneration of key management personnel

There was no Key management personnel remuneration during this year or last year.

12 Gains and losses on investments

Unrestricted Unrestricted
funds funds
2024 2023
Gains/(losses) arising on: £ £
Revaluation of investments (25,903) 4,574

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

13 Taxation

The charity is exempt from taxation on its activities because all its income is applied for charitable purposes.

14 Intangible fixed assets

Intangible fixed assets
Computer
software and
website
£
Cost
At 1 January 2024 89,595
Additions - separately acquired 4,231
At 31 December 2024 93,826
Amortisation and impairment
At 1 January 2024 36,436
Amortisation charged for the year 30,570
At 31 December 2024 67,006
Carrying amount
At 31 December 2024 26,820
At 31 December 2023 53,159

15 Tangible fixed assets

Fixtures and
fittings
ComputersChain of Office
£
£
£
Cost
At 1 January 2024
2,329
889
4,064
At 31 December 2024
2,329
889
4,064
Depreciation and impairment
At 1 January 2024
2,171
706
3,116
Depreciation charged in the year
24
46
352
At 31 December 2024
2,195
752
3,468
Carrying amount
At 31 December 2024
134
137
596
At 31 December 2023
158
183
948		 Total
£
7,282
7,282
5,993
422
6,415
867
1,289

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2024

16 Fixed asset investments

Listed
investments
£
Cost or valuation
At 1 January 2024 506,712
Additions 40,316
Valuation changes (25,903)
At 31 December 2024 521,125
Carrying amount
At 31 December 2024 521,125
At 31 December 2023 506,712

Fixed asset investments revalued

The investments are included at market value at the balance sheet date. Their historical cost at the balance sheet date is £542,454 (2023 - £502,138).

17 Stocks

Presidential Badges
18
Debtors
Amounts falling due within one year:
Trade debtors
Other debtors
Accrued income
Prepayments		 2024
£
15,891
2024
£
1,271
170,267
26,530
150,336
348,404		 2023
£
17,113
2023
£
21,500
176,590
33,133
150,109
381,332

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

19 Creditors: amounts falling due within one year

Creditors: amounts falling due within one year
Other taxation and social security
Trade creditors
Other creditors
Accruals and deferred income		 2024
£
-
6,855
607
32,026
39,488		 2023
£
12,331
13,956
299
43,065
69,651

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

20 Retirement benefit schemes

The company participates in the Superannuation Arrangements of the University of London (“SAUL”), which is a centralised defined benefit scheme within the United Kingdom and was contracted out of the Second State Pension (prior to April 2016).

SAUL is an independently-managed pension scheme for the non-academic staff of over 50 colleges and institutions with links to higher education.

Pension benefits accrued within SAUL currently build up on a Career Average Revalued Earnings (“CARE”) basis.

The company is not expected to be liable to SAUL for any other current participating employer’s obligations under the Rules of SAUL, but in the event of an insolvency of any participating employer within SAUL, an amount of any pension shortfall (which cannot otherwise be recovered) in respect of that employer, may be spread across the remaining participating employers and reflected in the next actuarial valuation.

Funding Policy

SAUL’s statutory funding objective is to have sufficient and appropriate assets to meet the costs incurred by the Trustee in paying SAUL’s benefits as they fall due (the “Technical Provisions”). The Trustee adopts assumptions which, taken as a whole, are intended to be sufficiently prudent for pensions and benefits already in payment to continue to be paid and for the commitments which arise from Members’ accrued pension rights to be met.

The Technical Provisions assumptions include appropriate margins to allow for the possibility of events turning out worse than expected. However, the funding method and assumptions do not completely remove the risk that the Technical Provisions could be insufficient to provide benefits in the future.

A formal actuarial valuation of SAUL is carried out every three years by a professionally qualified and independent actuary. The last actuarial valuation was carried out with an effective date of 31 March 2023. Informal reviews of SAUL’s position, reflecting changes in market conditions, cash flow information and new accrual of benefits, are carried out between formal valuations.

The funding principles were agreed by the Trustee and employers in June 2024 and will be reviewed again at SAUL’s next formal valuation in 2026.

At the 31 March 2023 valuation SAUL was 105% funded on its Technical Provisions basis. As SAUL was in surplus on its Technical Provisions basis, no deficit contributions were required. The Trustee and the Employers have agreed that the ongoing Employers’ contributions will fall from a rate of 21% of CARE Salaries to 19% of CARE Salaries from 1 September 2024.

The total cost of pension contributions on behalf of employees of the company during the year was £17,111 (2023 - £17,438).

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

21 Restricted funds

The restricted funds of the charity comprise the unexpended balances of donations and grants held on trust subject to specific conditions by donors as to how they may be used.

At 1 January Incoming Resources At 31
2024 resources expended December
2024
£ £ £ £
Laparoscopic Colorectal Surgery Bursaries 7,532 - - 7,532
Scottish Chapter 1,000 - - 1,000
EYCN Sponsorship - Education event - 3,000 (1,646) 1,354
8,532 3,000 (1,646) 9,886
Previous year: At 1 January Incoming Resources At 31
2023 resources expended December
2023
£ £ £ £
Laparoscopic Colorectal Surgery Bursaries 7,532 - - 7,532
Scottish Chapter 1,000 - - 1,000
8,532 - - 8,532

Covidien historically provided an educational grant of £25,000 to provide travelling bursaries for consultants and colorectal surgeons in training that are members of the ACPGBI to obtain experience of laparoscopic colorectal surgery in the UK and Europe. During 2024, £nil of these bursaries were utilised. £7,532 remains available.

The Scottish Chapter restricted fund relates to a donation received for the benefit of the Scottish Chapter. £1,000 remains available.

The Early Years Consultant Network (EYCN) fund is specifically for ACPGBI members in their transition to consultant life and through the first five years of practice. £1,354 remains available.

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (REFERRED TO AS ACPGBI) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

22 Analysis of net assets between funds

Unrestricted
Restricted
funds
funds
2024
2024
£
£
Fund balances at 31 December 2024 are represented by:
Intangible fixed assets
26,820
-
Tangible assets
867
-
Investments
521,125
-
Current assets/(liabilities)
1,214,421
9,886
1,763,233
9,886
Unrestricted
Restricted
funds
funds
2023
2023
£
£
Fund balances at 31 December 2023 are represented by:
Intangible fixed assets
53,159
-
Tangible assets
1,289
-
Investments
506,712
-
Current assets/(liabilities)
1,334,814
8,532
1,895,974
8,532
23
Related party transactions
There were no disclosable related party transactions during the year (2023 - none).
24
Cash generated from operations
2024
£
(Deficit)/surpus for the year
(131,387)
Adjustments for:
Investment income recognised in statement of financial activities
(15,316)
Fair value gains and losses on investments
25,903
Amortisation and impairment of intangible assets
30,570
Depreciation and impairment of tangible fixed assets
422
Movements in working capital:
Decrease/(increase) in stocks
1,222
Decrease in debtors
32,928
(Decrease) in creditors
(30,163)
Cash (absorbed by)/generated from operations
(85,821)		 Total
2024
£
26,820
867
521,125
1,224,307
1,773,119
Total
2023
£
53,159
1,289
506,712
1,343,346
1,904,506
2023
£
335,658
(2,138)
(4,574)
17,919
89
(17,113)
79,493
(34,035)
375,299

THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND

(REFERRED TO AS ACPGBI) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

25 Analysis of changes in net funds

The charity had no material debt during the year.